Quantum Promises in Pharma Business explores how quantum computing could fundamentally transform the pharmaceutical industry—from drug discovery and molecular simulation to clinical trials, supply chains, manufacturing, and personalised medicine.
In this episode of Center of Excellence – Pharma 4.0, we explore:
Why combinatorial explosion creates a major computational barrier for traditional computing.
How quantum computing could transform molecular simulation and drug design.
The role of quantum optimisation in clinical trials, supply chains, manufacturing, and portfolio decisions.
How quantum machine learning could uncover complex patterns in genomic and chemical data.
Why post-quantum security must evolve alongside quantum capabilities.
How quantum technologies could potentially reduce R&D costs, development timelines, and failure rates.
The potential for economically viable precision and rare-disease therapies.
The five pillars for preparing pharma organisations for the quantum era:
High-value problems
Quality and quantum-ready data
Hybrid quantum-classical pilots
Skills and ecosystem
Responsible governance
Why the future depends on combining pharma expertise + AI + quantum + strategic partnerships.
The episode concludes with a thought-provoking question around ownership, privacy, security, and control of digitally simulated biological identities in a post-quantum world.
Podden och tillhörande omslagsbild på den här sidan tillhör
Dr. Jayant Joshi. Innehållet i podden är skapat av Dr. Jayant Joshi och inte av,
eller tillsammans med, Poddtoppen.
